The accuracy of HPV genotyping in isolation and in combination with CD4 and HIV viral load for the identification of HIV-infected women at risk for developing cervical cancer.
Chandrika J PiyathilakeSuguna BadigaGreer A BurkholderShuko HaradaJames L RaperPublished in: Cancer medicine (2021)
Our results provide a more accurate tool for managing HIV+ women by combining Cobas HPV with CD4 and VL, especially those who had an undesirable pre-cART CD4 and VL status. Our results also indicate the usefulness of CD4 and VL measurements to identify those at lower risk in the absence of HPV testing.
Keyphrases
- hiv infected
- antiretroviral therapy
- cervical cancer screening
- hiv positive
- human immunodeficiency virus
- high grade
- polycystic ovary syndrome
- hiv aids
- hiv testing
- pregnancy outcomes
- men who have sex with men
- pregnant women
- dna methylation
- type diabetes
- gene expression
- metabolic syndrome
- south africa
- adipose tissue
- mass spectrometry
- genetic diversity